Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of ECMO on the Pharmacokinetics of Hydromorphone

NCT05565495 is registered in ClinicalTrials.gov with Xiaobo Yang, MD as lead sponsor.

NCT NCT05565495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05565495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of ECMO on the Pharmacokinetics of Hydromorphone
Lead sponsor
Xiaobo Yang, MD
Phase
Phase 2
Overall status
Recruiting
Start date
January 1, 2022
Completion date
September 1, 2024
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extracorporeal membrane oxygenation